Matches in Nanopublications for { ?s ?p "[An increase in the cellular levels of dihydrofolate reductase (DHFR) is one of the most common mechanisms of tumor resistance to methotrexate (MTX), an antimetabolite that is widely used in the treatment of a variety of human malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP845581.RAVXy10jiL6lb8Wc4DU1DNYwFz5wFB79tMYADuCiFspK8130_assertion description "[An increase in the cellular levels of dihydrofolate reductase (DHFR) is one of the most common mechanisms of tumor resistance to methotrexate (MTX), an antimetabolite that is widely used in the treatment of a variety of human malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845581.RAVXy10jiL6lb8Wc4DU1DNYwFz5wFB79tMYADuCiFspK8130_provenance.
- NP432785.RAU4mGFkJ30N7PoUDISpfd-onUHVmjF-CjD8B0xNeRxMA130_assertion description "[An increase in the cellular levels of dihydrofolate reductase (DHFR) is one of the most common mechanisms of tumor resistance to methotrexate (MTX), an antimetabolite that is widely used in the treatment of a variety of human malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432785.RAU4mGFkJ30N7PoUDISpfd-onUHVmjF-CjD8B0xNeRxMA130_provenance.
- NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_assertion description "[An increase in the cellular levels of dihydrofolate reductase (DHFR) is one of the most common mechanisms of tumor resistance to methotrexate (MTX), an antimetabolite that is widely used in the treatment of a variety of human malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_provenance.